These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 25816032)
1. Solid serous cystadenoma of the pancreas: a case report of 2 patients revealing vimentin, β-catenin, α-1 antitrypsin, and α-1 antichymotrypsin as new immunohistochemistry staining markers. Wu W; Hong X; Li J; Dai M; Wang W; Tong A; Zhu Z; Dai H; Zhao Y Medicine (Baltimore); 2015 Mar; 94(12):e644. PubMed ID: 25816032 [TBL] [Abstract][Full Text] [Related]
2. INSM1 is a useful neuroendocrine marker to differentiate pancreatic serous cystadenoma from pancreatic well-differentiated neuroendocrine tumors in cytology and surgical specimens. Chi Z; Xu J; Karamchandani DM; Peng L Ann Diagn Pathol; 2024 Aug; 71():152304. PubMed ID: 38614035 [TBL] [Abstract][Full Text] [Related]
3. [Clinical features and prognosis of solid-pseudopapillary tumor of the pancreas]. Zhang YW; Yan DL; Sun L; Zheng SW; Xue HZ; Wang XH; Wang TH Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):444-7. PubMed ID: 20819487 [TBL] [Abstract][Full Text] [Related]
4. [Clinicopathologic analysis of 92 cases of pancreatic cystic neoplasm]. Ji Y; Zhu XZ; Lou WH; Wang DQ; Jin DY; Zeng MS; Zeng HY Zhonghua Bing Li Xue Za Zhi; 2007 Mar; 36(3):160-5. PubMed ID: 17535681 [TBL] [Abstract][Full Text] [Related]
5. Pancreatic neuroendocrine tumor and solid-pseudopapillary neoplasm: Key immunohistochemical profiles for differential diagnosis. Ohara Y; Oda T; Hashimoto S; Akashi Y; Miyamoto R; Enomoto T; Satomi K; Morishita Y; Ohkohchi N World J Gastroenterol; 2016 Oct; 22(38):8596-8604. PubMed ID: 27784972 [TBL] [Abstract][Full Text] [Related]
6. Nuclear expression of E-cadherin in solid pseudopapillary tumors of the pancreas. Serra S; Salahshor S; Fagih M; Niakosari F; Radhi JM; Chetty R JOP; 2007 May; 8(3):296-303. PubMed ID: 17495358 [TBL] [Abstract][Full Text] [Related]
7. Solid and cystic tumor of the pancreas: clinicopathologic and genetic studies of four cases. Yamaue H; Tanimura H; Shono Y; Onishi H; Tani M; Yamoto H; Kinoshita H; Uchiyama K Int J Pancreatol; 2000 Feb; 27(1):69-76. PubMed ID: 10811026 [TBL] [Abstract][Full Text] [Related]
8. Fine-needle aspirations of pancreatic serous cystadenomas: improving diagnostic yield with cell blocks and α-inhibin immunohistochemistry. Salomao M; Remotti H; Allendorf JD; Poneros JM; Sethi A; Gonda TA; Saqi A Cancer Cytopathol; 2014 Jan; 122(1):33-9. PubMed ID: 23939868 [TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical investigation of vimentin, neuron-specific enolase, alpha 1-antichymotrypsin and alpha 1-antitrypsin in adenoid cystic carcinoma of the salivary gland. Takahashi H; Tsuda N; Fujita S; Tezuka F; Okabe H Acta Pathol Jpn; 1990 Sep; 40(9):655-64. PubMed ID: 2175537 [TBL] [Abstract][Full Text] [Related]
12. DOG1 (clone K9) is seldom expressed and not useful in the evaluation of pancreatic neoplasms. Hemminger J; Marsh WL; Iwenofu OH; Frankel WL Appl Immunohistochem Mol Morphol; 2012 Jul; 20(4):397-401. PubMed ID: 22495382 [TBL] [Abstract][Full Text] [Related]
13. Pax8 as a useful adjunct marker to differentiate pancreatic serous cystadenoma from clear cell renal cell carcinoma in both cytologic and surgical specimens. Chi Z; Xu J; Karamchandani DM; Peng L Diagn Pathol; 2023 Apr; 18(1):54. PubMed ID: 37098593 [TBL] [Abstract][Full Text] [Related]
14. Macrocystic serous cystadenoma of the pancreas: clinicopathologic features in seven cases. Sperti C; Pasquali C; Perasole A; Liessi G; Pedrazzoli S Int J Pancreatol; 2000 Aug; 28(1):1-7. PubMed ID: 11185705 [TBL] [Abstract][Full Text] [Related]
15. EUS-FNA diagnosis of pancreatic serous cystadenoma with the aid of cell blocks and α-inhibin immunochemistry: A case series. Sydney GI; Ioakim KJ; Michaelides C; Sepsa A; Sopaki-Valalaki A; Tsiotos GG; Theocharis S; Salla C; Nikas I Diagn Cytopathol; 2020 Mar; 48(3):239-243. PubMed ID: 31785091 [TBL] [Abstract][Full Text] [Related]
16. Serous cystic neoplasms of the pancreas: an immunohistochemical analysis revealing alpha-inhibin, neuron-specific enolase, and MUC6 as new markers. Kosmahl M; Wagner J; Peters K; Sipos B; Klöppel G Am J Surg Pathol; 2004 Mar; 28(3):339-46. PubMed ID: 15104296 [TBL] [Abstract][Full Text] [Related]
17. Cytohistological diagnosis of pancreatic serous cystadenoma: a multimodal approach. Steel M; Rao S; Ho J; Donnellan F; Yang HM; Schaeffer DF J Clin Pathol; 2019 Sep; 72(9):615-621. PubMed ID: 31235542 [TBL] [Abstract][Full Text] [Related]
18. A case of serous cystadenoma of the pancreas with focal malignant changes. Ohta T; Nagakawa T; Itoh H; Fonseca L; Miyazaki I; Terada T Int J Pancreatol; 1993 Dec; 14(3):283-9. PubMed ID: 8113630 [TBL] [Abstract][Full Text] [Related]
19. Serous Cystadenoma of the Pancreas With Complex Florid Papillary Architecture: A Case Report and Review of the Literature. Tracht J; Reid MD; Hissong E; Sekhar A; Sarmiento J; Krasinskas A; Xue Y Int J Surg Pathol; 2019 Dec; 27(8):907-911. PubMed ID: 31187681 [TBL] [Abstract][Full Text] [Related]
20. [Microcystic serous cystadenoma: An uncommon neoplasm of pancreas. Report of two cases]. Legrand M; Delalande F; Blechet C; Kerdraon R; Saint-Marc O; Michenet P Ann Pathol; 2019 Aug; 39(4):292-296. PubMed ID: 30711334 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]